Search Results
Results found for "Novo Nordisk Foundation"
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
GPCR imaging is evolving from a specialized technique into a foundational method for receptor biology
- Understanding the Journey: Catherine Demery's Path to Addiction Science
She found herself drawn toward the science behind the drugs, rather than their clinical application. Catherine’s methodical retention of those skills later gave her a solid foundation in her academic work
- Your GPCR Program Decisions Depend on Good Data Interpretation
excellence His approach didn’t just create a productive lab—it accelerated outcomes and laid the cultural foundation
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
molecular determinants of ligand efficacy and potency in GPCR signalling, this research provides a foundation
- Quantifying Receptor Selectivity in Modern Drug Discovery
Another produces a larger shift in EC₅₀ in one system than another, and we assume we’ve found therapeutic It is designed for: Pharmacologists sharpening foundational tools Discovery teams solving assay bottlenecks
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
Catherine’s work lays the foundation for designing better interventions, from preclinical models to clinical
- Drug Discovery Pharmacology Principles That Turn Assays Into Real Medicines
The scientists who strengthen their pharmacology foundations today will define tomorrow’s breakthroughs
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with pioneer as co-founder The company's co-founder, GPCR pioneer and Nobel laureate Robert Lefkowitz, M.D., has 50 years of experience
- Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in ...
protein-coupled receptors (GPCRs) and it participates in inflammatory and immune responses that have been found In vivo, we found that inhibition of GRP78-ATF6-CHOP apoptosis signaling improved ESS symptoms, and the This research further clarified the underlying role of β-arrestin2 and provided an experimental foundation
- From Lab Bench to Boardroom: The Unexpected Path of a Medicinal Chemist
GPCR Podcast, she shares how her background in medicinal chemistry paved the way to co-founding Celtarys However, as she and her co-founders soon realized, commercializing it was the only way to deliver that
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
Clark , laid the foundation for today’s quantitative pharmacology.
- 📰 GPCR Weekly News, February 13 to 19, 2023
Hauser on receiving 4.8 mill DKK from Carlsberg Foundation’s Semper Ardens: Accelerate programme.
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
Early optimization prevents later variability and sets the foundation for scalable screening. 2.
- 📰 GPCR Weekly News, April 24 to 30, 2023
LSX World Congress Novel living yeast-based dual biosensor for detecting peptide variants The Galien Foundation
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
. 🌟 Speaker Spotlight In the run-up to the conference, our founder Yamina Berchiche is speaking with At Yamina's Corner , our founder Yamina Berchiche works closely with organizations to help them navigate
- Targeting Intracellular Allosteric Sites in GPCRs
understanding of GPCR biased signaling induced by intracellular allosteric agonists and establish a strong foundation
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
The physical barrier this lipid bilayer creates is dynamic and interactive, becoming the foundation for
- Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools
Yamina Berchiche , Founder and CEO of Dr. GPCR.
- Dr. GPCR and Eurofins DiscoverX Join Forces to Accelerate GPCR Drug Discovery
Yamina Berchiche, Founder and CEO of Dr. GPCR .
- Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders with ...
Treat Dyskinesia and Other Movement Disorders with Tim Dyer Addex Therapeutics "Tim Dyer is the Co-Founder
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
Maria Majellaro shares her journey to founding Celtarys in "From Lab to Leadership". Story Behind Celtarys – From Chemistry to Company How does a medicinal chemist become a biotech founder Maria Majellaro’s path from lab research to co-founding Celtarys, as told in her recent Dr.
- Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools
Yamina Berchiche, Founder of Dr. GPCR.
- Accelerating GPCR Drug Discovery
In every role and sector, I found myself drawn to the same critical challenges: missed opportunities, GPCR As the co-founder of Dr.
- GPCR Drug Discovery Summit 2026: What to Expect in Boston — and How to Register
GPCR founder Dr. Yamina Berchiche will be there — if you're attending, reach out to connect.
- From GPCR Data Chaos to Decisive Action
Real-Time Global Insight As founder of Dr.
- 📰 GPCR Weekly News, February 19 to 25, 2024
GPCR Founder Dr. Yamina Berchiche at the 3rd GPCRs Summit in Boston on March 5-7, 2024. Dr. GPCR Founder Dr.
- Adhesion GPCR Consortium Newsletter - May 2024
shocked that I wasn’t asked if I was a student or a PI, I was more proud to say that I was coming as the founder I, in turn, recruited Yamina Berchiche, founder of DrGPCR.com, to join me in this endeavor.
- Molecular creativity in drug discovery
Highlights: • The Foundry Arrives : R&D meets biotech with real-world acceleration, strategic consulting
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
No substantial differences were found between them and the reporter. Figure 4. and Treatment of Dopaminergic Augmentation: A Combined Task Force of the IRLSSG, EURLSSG, and the RLS-Foundation
- 📰 GPCR Weekly News, July 3 to 9, 2023
Trial Assessing GTAEXS617 in Advanced Solid Tumours A Conversation with Murat Tunaboylu, Antiverse Co-Founder





















